A detailed history of Nordea Investment Management Ab transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Nordea Investment Management Ab holds 725,363 shares of GILD stock, worth $64.3 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
725,363
Previous 987,217 26.52%
Holding current value
$64.3 Million
Previous $67.7 Million 10.24%
% of portfolio
0.07%
Previous 0.08%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$66.59 - $83.99 $17.4 Million - $22 Million
-261,854 Reduced 26.52%
725,363 $60.8 Million
Q2 2024

Aug 08, 2024

SELL
$63.15 - $72.88 $3.08 Million - $3.55 Million
-48,708 Reduced 4.7%
987,217 $67.7 Million
Q1 2024

May 02, 2024

SELL
$71.58 - $87.29 $6.29 Million - $7.67 Million
-87,815 Reduced 7.81%
1,035,925 $75.9 Million
Q4 2023

Jan 10, 2024

BUY
$73.27 - $83.09 $28.3 Million - $32 Million
385,630 Added 52.25%
1,123,740 $91 Million
Q3 2023

Nov 13, 2023

SELL
$73.94 - $80.67 $961,441 - $1.05 Million
-13,003 Reduced 1.73%
738,110 $55.3 Million
Q2 2023

Jul 07, 2023

SELL
$76.01 - $86.7 $3.45 Million - $3.93 Million
-45,330 Reduced 5.69%
751,113 $57.9 Million
Q1 2023

Apr 19, 2023

SELL
$77.31 - $88.08 $1.3 Million - $1.48 Million
-16,785 Reduced 2.06%
796,443 $66.1 Million
Q4 2022

Feb 08, 2023

SELL
$62.32 - $89.47 $4.8 Million - $6.89 Million
-76,969 Reduced 8.65%
813,228 $69.8 Million
Q3 2022

Oct 19, 2022

SELL
$59.54 - $68.01 $6.51 Million - $7.43 Million
-109,308 Reduced 10.94%
890,197 $56.2 Million
Q2 2022

Aug 09, 2022

SELL
$57.72 - $65.01 $5.68 Million - $6.39 Million
-98,320 Reduced 8.96%
999,505 $61.6 Million
Q1 2022

Apr 11, 2022

SELL
$57.92 - $72.58 $2.38 Million - $2.98 Million
-41,082 Reduced 3.61%
1,097,825 $65.7 Million
Q4 2021

Jan 20, 2022

BUY
$64.88 - $73.64 $4.14 Million - $4.7 Million
63,845 Added 5.94%
1,138,907 $83.4 Million
Q3 2021

Nov 01, 2021

SELL
$67.69 - $73.03 $72.8 Million - $78.5 Million
-1,075,062 Reduced 50.0%
1,075,062 $76.4 Million
Q3 2021

Nov 01, 2021

BUY
$67.69 - $73.03 $72.8 Million - $78.6 Million
1,076,074 Added 100.19%
2,150,124 $150 Million
Q2 2021

Jul 16, 2021

BUY
$63.47 - $69.35 $74,006 - $80,862
1,166 Added 0.11%
1,074,050 $74 Million
Q1 2021

May 17, 2021

SELL
$60.0 - $68.46 $12.2 Million - $13.9 Million
-203,610 Reduced 15.95%
1,072,884 $69.4 Million
Q4 2020

Feb 12, 2021

SELL
$56.65 - $64.55 $838,816 - $955,791
-14,807 Reduced 1.15%
1,276,494 $74.4 Million
Q3 2020

Nov 09, 2020

SELL
$62.1 - $78.08 $28.3 Million - $35.6 Million
-455,341 Reduced 26.07%
1,291,301 $80.7 Million
Q2 2020

Aug 13, 2020

BUY
$72.34 - $84.0 $64.2 Million - $74.6 Million
887,810 Added 103.37%
1,746,642 $134 Million
Q1 2020

May 15, 2020

SELL
$62.63 - $80.22 $1.86 Million - $2.38 Million
-29,666 Reduced 3.34%
858,832 $64.2 Million
Q4 2019

Feb 11, 2020

SELL
$61.62 - $67.78 $587,669 - $646,417
-9,537 Reduced 1.06%
888,498 $57.3 Million
Q3 2019

Nov 13, 2019

SELL
$62.51 - $69.0 $293,359 - $323,817
-4,693 Reduced 0.52%
898,035 $56.9 Million
Q2 2019

Aug 14, 2019

SELL
$61.87 - $69.38 $11.9 Million - $13.4 Million
-193,043 Reduced 17.62%
902,728 $61 Million
Q1 2019

May 20, 2019

BUY
$62.53 - $70.05 $4.35 Million - $4.88 Million
69,597 Added 6.78%
1,095,771 $71.2 Million
Q4 2018

Feb 14, 2019

BUY
$60.54 - $79.0 $7.7 Million - $10 Million
127,140 Added 14.14%
1,026,174 $64.2 Million
Q3 2018

Nov 14, 2018

SELL
$71.28 - $78.92 $1.36 Million - $1.5 Million
-19,018 Reduced 2.07%
899,034 $69.4 Million
Q2 2018

Aug 13, 2018

SELL
$64.88 - $75.68 $207,745 - $242,327
-3,202 Reduced 0.35%
918,052 $65 Million
Q1 2018

May 14, 2018

SELL
$72.84 - $88.8 $1.07 Million - $1.3 Million
-14,628 Reduced 1.56%
921,254 $69.5 Million
Q4 2017

Feb 12, 2018

SELL
$71.15 - $83.52 $18.5 Million - $21.7 Million
-259,583 Reduced 21.71%
935,882 $67 Million
Q3 2017

Nov 09, 2017

BUY
$72.11 - $85.47 $86.2 Million - $102 Million
1,195,465
1,195,465 $96.9 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $111B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.